Accustem Sciences Inc. financial data

Symbol
ACUT on OTC
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 30.5 % +720%
Debt-to-equity -144 % -38.4%
Return On Equity 59.1 % +15.9%
Return On Assets -135 % +89.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16.1M shares +41.6%
Common Stock, Shares, Outstanding 16.1M shares +41.6%
Entity Public Float 2.18M USD -86.4%
Common Stock, Value, Issued 16.1K USD +41.7%
Weighted Average Number of Shares Outstanding, Basic 16.1M shares +41.6%
Weighted Average Number of Shares Outstanding, Diluted 16.1M shares +41.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 203K USD +9.34%
General and Administrative Expense 1.41M USD +18.2%
Operating Income (Loss) -1.61M USD -17%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.61M USD -17%
Net Income (Loss) Attributable to Parent -1.61M USD -17%
Earnings Per Share, Basic 0 USD/shares +23.1%
Earnings Per Share, Diluted 0 USD/shares +23.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Other Assets, Current 1.5M USD
Assets, Current 1.57M USD +1435%
Property, Plant and Equipment, Net 105 USD -96.7%
Assets 1.57M USD +1415%
Accounts Payable, Current 923K USD +16.8%
Accrued Liabilities, Current 150K USD -8.7%
Liabilities, Current 4.48M USD +36%
Liabilities 4.48M USD +36%
Retained Earnings (Accumulated Deficit) -9.27M USD -21.1%
Stockholders' Equity Attributable to Parent -2.91M USD +8.85%
Liabilities and Equity 1.57M USD +1415%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -290K USD -22.3%
Net Cash Provided by (Used in) Financing Activities 322K USD +42.7%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 16.1M shares +41.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 31.3K USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 336 USD -51.8%
Deferred Tax Assets, Valuation Allowance 1.74M USD +28%
Depreciation 1.33K USD -63.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.79M USD -157%
Property, Plant and Equipment, Gross 11K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 1.59M USD +29.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 6.34M USD +42.5%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.74M USD +28%
Share-based Payment Arrangement, Expense 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%